What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.
AI automation, and more skilled staff are needed to ensure cancer patients can access potentially life-saving CAR T therapies.
The life science group Sartorius is launching an integrated system for the production and quality control (QC) of autologous cell therapies.
The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
The AMT designation gives Cellares’ clients using the Cell Shuttle priority review with the FDA leading to accelerated regulatory filings SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the ...
Cell Therapy Manufacturers · GlobeNewswire Inc. Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market (7th Edition): Trends and Forecast Till 2035 - Distribution by Type of ...
A new generation of automated technologies in cell and gene therapy manufacturing systems will help more people benefit according to research identifying high production cost as the main impediment to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results